CMAXmaximum concentration, Cmax
CMAXDdose normalized Cmax, CMAX / Dose, Cmax / Dose
TMAXtime of maximum concentration, Tmax
TLAGtime to observe the first non-zero concentration, for extravascular administration only
CLSTlast positive concentration observed, Clast
CLSTPlast positive concentration predicted, Clast_pred
TLSTtime of last positive concentration, Tlast
LAMZHLhalf-life by lambda z, ln(2)/LAMZ
LAMZlambda_z negative of best fit terminal slope
LAMZLLearliest time for LAMZ
LAMZULlast time for LAMZ
LAMZNPTnumber of points for LAMZ
CORRXYcorrelation of log(concentration) and time
R2R-squared
R2ADJR-squared adjusted
C0back extrapolated concentration at time 0, for bolus intravascular administration only
AUCLSTAUC from 0 to TLST
AUCALLAUC using all the given points, including trailing zero concentrations
AUCIFOAUC infinity observed
AUCIFODAUCIFO / Dose
AUCIFPAUC infinity predicted using CLSTP instead of CLST
AUCIFPDAUCIFP / Dose
AUCPEOAUC % extrapolation observed
AUCPEPAUC % extrapolated for AUCIFP
AUCPBEOAUC % back extrapolation observed, for bolus IV administration only
AUCPBEPAUC % back extrapolation predicted with AUCIFP, for bolus IV administration only
AUMCLSTAUMC to the TLST
AUMCIFOAUMC infinity observed using CLST
AUMCIFPAUMC infinity determined by CLSTP
AUMCPEOAUMC % extrapolated observed
AUMCPEPAUMC % extrapolated predicted
MRTIVLSTmean residence time (MRT) to TLST, for intravascular administration
MRTIVIFOmean residence time (MRT) infinity using CLST, for intravascular administration
MRTIVIFPmean residence time (MRT) infinity using CLSTP, for intravascular administration
MRTEVLSTmean residence time (MRT) to TLST, for extravascular administration
MRTEVIFOmean residence time (MRT) infinity using CLST, for extravascular administration
MRTEVIFPmean residence time (MRT) infinity using CLSTP, for extravascular administration
VZOvolume of distribution determined by LAMZ and AUCIFO, for intravascular administration
VZPvolume of distribution determined by LAMZ and AUCIFP, for intravascular administration
VZFOVZO for extravascular administration, VZO/F, F is bioavailability
VZFPVZP for extravascular administration, VZP/F, F is bioavailability
CLOclearance using AUCIFO, for intravascular administration
CLPclearance using AUCIFP, for intravascular administration
CLFOCLO for extravascular administration, CLO/F, F is bioavailability
CLFPCLP for extravascular administration, CLP/F, F is bioavailability
VSSOvolume of distribution at steady state using CLST, for intravascular administration only
VSSPvolume of distribution at stead state using CLSTP, for intravascular administration only